Editorial: PIVKA-II Facilitates Risk Stratification for HCC Following HCV Cure

Aliment Pharmacol Ther. 2024 Dec 26. doi: 10.1111/apt.18444. Online ahead of print.

Authors

Tung-Hung Su¹, Wei-Chih Liao^{1

2}

Affiliations

¹ Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
² Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.

PMID: 39723757
DOI: 10.1111/apt.18444

No abstract available

Publication types

Editorial